Limitations of FNAC in detecting parotid malignancies: insights from a surgical cohort using the updated Milan System.

Authors

Andrea Galli, Bright Oworae Howardson, Carlo Scionti, Emilio Salerno, Carlo Pettirossi, Davide Di Santo, Diego Barbieri, Apostolos Karligkiotis, Gianluigi Arrigoni, Renata Mellone, Stefano Bondi, Mario Bussi, Leone Giordano

Published in

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. Aug 03, 2026. Epub Aug 03, 2026.

Abstract

To evaluate the diagnostic accuracy of the second edition Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) in predicting the risk of malignancy (ROM) in parotid tumors, through correlation with final histopathological diagnoses in a large consecutive single-center surgical series.
A retrospective study was conducted on 249 consecutive patients who underwent parotid surgery between June 2017 and March 2024 in a tertiary referral center. Preoperative fine-needle aspiration cytology (FNAC) results were classified according to the MSRSGC. Diagnostic performance metrics were calculated, including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic concordance. Cytological findings were correlated with definitive histopathology to calculate ROM, risk of high-grade malignancy (ROM-HG), and risk of neoplasia (RON). Multivariate logistic regression was performed to identify preoperative predictors of malignancy.
FNAC showed high accuracy in diagnosing pleomorphic adenoma and Warthin tumor. Sensitivity for malignancy detection was 68%, In alternative analyses, sensitivity decreased to 56% and increased to 74% when indeterminate categories (MSRSGC III- AUS and IV - SUMP) were considered test-negative or test-positive, respectively.. Within these indeterminate categories, ROM was 18.6%, while ROM-HG was 0%. Among 29 primary malignant tumors, 86.7% of low/intermediate-grade malignancies were classified as benign or indeterminate on FNAC. Multivariate analysis identified male gender and hypomobility as predictors of malignancy.
Although the updated MSRSGC has improved FNAC-based classification of parotid tumors, diagnostic performance remains limited for low/intermediate-grade malignancies, which are frequently classified as benign or indeterminate. The absence of HG-malignancies within indeterminate categories suggests a limited clinical impact of these diagnostic uncertainty.

PMID:
42543414
Bibliographic data and abstract were imported from PubMed on 03 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.